The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe (201124)
ARTG Name
XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe
Product name
XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Ingredients
Omalizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information